pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,831
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Marketed
olutasidenib
Rezlidhia (olutasidenib)
Refractory Acute Myeloid Leukemia
$RIGL
RIGEL PHARMACEUTICALS INC
Phase 3
olverembatinib
olverembatinib
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…
$AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
Phase 3
olvimulogene nanivacirepvec
olvimulogene nanivacirepvec
Endometrial Cancer
$GNLX
GENELUX Corp
← prev
page 53 of 62
next →
Pain
89
Neurology
1
Marketed
omacetaxine mepesuccinate
omacetaxine mepesuccinate
Myelodysplastic Syndrome (Preleukemia)
$TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Marketed
omeprazole magnesium DR
Omeprazole Magnesium
Systemic Mastocytosis
Perrigo Pharmaceuticals Company (Inactive)
Phase 3
omidubicel
Omisirge (omidubicel-onlv)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…
Gamida Cell Ltd
Phase 2
ompenaclid succinate
ompenaclid succinate
Metastatic Colorectal Cancer
Inspirna Inc
Preclinical
onCARlytics
Triple-Negative Breast Cancer (TNBC)
Imugene Ltd
Phase 3
onfekafusp alfa
onfekafusp alfa [INN]
Soft Tissue Sarcoma
Philogen SpA
Phase 2
onvansertib fumarate
onvansertib fumarate
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
$CRDF
Cardiff Oncology, Inc.
Phase 2
onvapegleukin alfa
onvapegleukin alfa
Cervical Cancer
Ascendis Pharma AS
Phase 2
opaganib
YELIVA (opaganib [INN])
Bile Duct Cancer (Cholangiocarcinoma)
$RDHL
RedHill Biopharma Ltd.
Phase 2
ordastobart
ordastobart
Adenocarcinoma Of The Gastroesophageal Junction
$INBX
Inhibrx Biosciences, Inc.
Phase 3
oregovomab
Ovarex (oregovomab)
Fallopian Tube Cancer
OncoQuest Inc
Phase 3
orelabrutinib
orelabrutinib
Primary Progressive Multiple Sclerosis (PPMS)
$ZBIO
Zenas BioPharma, Inc.
Phase 2
orvacabtagene autoleucel
orvacabtagene autoleucel
Refractory Multiple Myeloma
Bristol-Myers Squibb Co
Phase 2
osemitamab
osemitamab
Gastroesophageal (GE) Junction Carcinomas
Transcenta Holding Ltd
Marketed
osimertinib mesylate
Tagrisso (osimertinib mesylate)
Non-Small Cell Lung Cancer
$AZN
ASTRAZENECA PLC
pre_registration
ozekibart
ozekibart
Chondrosarcoma
$INBX
Inhibrx Biosciences, Inc.
Phase 2
ozuriftamab vedotin
ozuriftamab vedotin
Head And Neck Cancer
$BCAB
BioAtla, Inc.
Marketed
paclitaxel albumin bound
Abraxane (paclitaxel)
Non-Small Cell Lung Cancer
Celgene Corp
Phase 3
padeliporfin potassium
padeliporfin potassium
Transitional Cell Cancer (Urothelial Cell Cancer)
ImPact Biotech Limited
Phase 2
palacaparib
palacaparib [INN]
Malignant Glioma
$AZN
ASTRAZENECA PLC
Phase 3
palazestrant
palazestrant
Human Epidermal Growth Factor Receptor 2 Negative Breast…
$OLMA
Olema Pharmaceuticals, Inc.
Marketed
palbociclib
Ibrance (palbociclib)
Breast Cancer
$OTLC
Oncotelic Therapeutics, Inc.
Marketed
pamidronate disodium
Pamidronate Disodium
Osteolytic Lesion
Areva Pharmaceuticals Inc
Phase 2
pamlectabart tismanitin
pamlectabart tismanitin [INN]
Refractory Multiple Myeloma
Heidelberg Pharma AG
Marketed
panitumumab
Vectibix (panitumumab)
Metastatic Colorectal Cancer
$AMGN
AMGEN INC
Phase 3
pasritamig
pasritamig
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
$JNJ
JOHNSON & JOHNSON
Phase 3
patidegib hydrochloride
patidegib hydrochloride
Gorlin Syndrome (Basal Cell Nevus Syndrome/ Nevoid Basal…
$SLGL
Sol-Gel Technologies Ltd.
